InSyBio https://validator.w3.org/feed/docs/rss2.html Fixed-Price Micro-Analysis Services Short-Term Access Passes InSyBio Suite Pricing InSyBio Suite Version 3.4 is announced, introducing a major upgrade of the InSyBio Interact tool for advanced protein interaction analysis and biological network discovery Position: Full Stack Web Developer  New Scientific Publication on Bone Regeneration within the REGENERATION Project InSyBio Accepted into the A4SUSTINNO Accelerator Programme Successful Completion of the GALATEA Midterm Meeting in Athens InSyBio Biomarkers InSyBio DNASeq InSyBio Pipelines InSyBio ncRNASeq InSyBio Datastore InSyBio BioNets InSyBio Interact InSyBio Advances Understanding of Molecular Mechanisms Involved in Human Taste Using Machine-Learning and Network Analytics Position 1: Junior Software Engineer Developer Position: Junior Business Development Associate Job Openings Machine learning algorithms, using ensemble and oversampling techniques for Glioblastoma Multiforme Diagnosis InSyBio @Upatras Osteoarthritis Tool InSyBio Selected for the Start4Health ScaleUps Studio Programme Precision Chronic Pain Treatment Tools Mass Spectrometry Proteomics Data : From raw data to discovery InSyBio announces Novel of Multiple Taste Predictor based on a Multiobjective Machine Learning method InSyBio enters Loyal VC investment Stage 2 and initiates the next financing round InSyBio Chronic Pain Precision Relief @Kailo Tool InSyBio Chronic Pain Precision Relief @Salonpas Tool InSyBio Chronic Pain Precision @Topical Analgesics Tool InSyBio Suite Version 3.2 is released including an integrated workflow and toolbox for single-cell RNA-sequencing analysis InSyBio Suite Version 3.1 is released facilitating interactive and efficient network and machine-learning driven multi-omics data analysis InSyBio recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery Precision Treatment Tools for Cardiovascular Diseases Metabolic AI™ Fitly Health & InSyBio have partnered to create the world’s first Metabolic AI™ precision nutrition program for metabolic syndrome, prediabetes, and Type 2 diabetes Contact Us InSyBio White Papers What we are doing at InSyBio? Download RNA-Seq White Paper of InSyBio Suite Understanding Taste by Studying the Protein-Protein Interactions of Taste Receptors InSyBio wins the Investor Prize in the category of Big Data for Health in Sanofi’s Labs in the VivaTech 2017 event InSyBio makes the big step to the USA biotechnology market with the help of International Accelerator! InSyBio Harnesses the Power of Clinical Data developing AI tools for Cardiovascular Disease Treatment Optimization InSyBio Suite V2.4 has been launched and includes for the first time the InSyBio Biomarkers Tool InSyBio reveals novel diagnostic and prognostic biosignature for Glioblastoma and announces its presentation at the 11th annual RECOMB/ISCB Conference on Regulatory & Systems Genomics InSyBio Diagnostics InSyBio Suite V2.5 has been launched and Includes for the first time a complete pipeline for the analysis of RNA-sequencing data InSyBio awarded on Ignite Ideas program organised by Nestle Hellas Welcome